GeneDx Holdings Corp.
WGS
$70.69
-$4.81-6.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 59.80% | 102.49% | 101.20% | 71.43% | 70.25% |
| Total Depreciation and Amortization | 15.54% | 44.76% | 20.52% | -9.53% | -22.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 65.83% | -9.84% | -59.34% | 241.64% | 565.91% |
| Change in Net Operating Assets | 36.97% | 6.82% | 22.71% | 66.39% | 35.29% |
| Cash from Operations | 216.78% | 160.15% | 114.16% | 98.65% | 84.18% |
| Capital Expenditure | -246.33% | -267.86% | -184.71% | -96.33% | -4.59% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 60.86% | 99.84% | 82.70% | -2.05% | 18.85% |
| Cash from Investing | -104.16% | -47.82% | -0.34% | 4.80% | 31.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -13.55% | -42.57% | -18.81% | -21.94% | 42.39% |
| Issuance of Common Stock | 9.07% | 306.35% | 34,930.00% | 715.04% | -66.93% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 8.75% | -7.28% | 30.18% | 9.74% | -76.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 236.78% | 229.49% | 117.96% | 112.31% | 61.56% |